Medunik Canada

6 articles about Medunik Canada

• SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states

  9/21/2023

  Medunik USA is pleased to announce that government coverage of Siklos® under State Medicaid programs is now available in 19 states: 5 states with preferred coverage: FL, TX, WI, & WY as well as on the Contract Drug List in California, and covered in another 14 states with prior authorizations*, in addition to the expanding commercial coverage for the benefit of Americans with sickle cell anemia.

• Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing

  11/19/2018

  Medunik USA is proud to announce today that Siklos® (hydroxyurea), an FDA-approved orphan drug, is now available in 1,000 mg triple-scored tablets to help optimize dosing.

• Medunik Canada Is Pleased To Announce The Launch Of National Organization for Rare Disorders Founder, Abbey Meyers' Memoir "Orphan Drugs: A Global Crusade"

  2/16/2016

• PHEBURANE Now Available For Distribution In Canada Through Medunik Canada

  3/30/2015

• Medunik Canada Is Pleased To Announce That Health Canada Has Granted Market Authorization For Pheburane™

  1/27/2015

• Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD)

  9/24/2014